SEC Form 4 · accession 0001415889-17-000407
ACADIA PHARMACEUTICALS INC · ACAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terrence O Moore
Officer — EVP, CHIEF COMMERCIAL OFFICER
Period of report
Mar 8, 2017
Accepted (ET)
Mar 10, 2017 · 8:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070494
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $36.54 | Mar 8, 2017 | A | 33,750 | A | — | Mar 7, 2027 | Common Stock | 33,750 | 33,750 | D |
Explanation of responses
- F125% of the shares subject to the Stock Option vest and become exercisable on March 8, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.